Meet
David Kowalsky

David Kowalsky partners with pharmaceutical companies to develop market access and patient support strategies.

David has extensive therapeutic experience in diabetes, obesity, ophthalmology, and rare diseases. He applies his background in coverage, pricing, reimbursement, and patient experience to a broad range of client projects.

Prior to joining Avalere, David was the director of Patient and Market Access at EyePoint Pharmaceuticals within the Market Access and Government Affairs department, supporting long-range planning of access and reimbursement programs optimization, field reimbursement development, pricing strategy, and reimbursement education across matrix teams. Prior to that, David worked at Novo Nordisk in a variety of roles spanning pricing strategy, financial planning and analysis, strategy and business planning, procurement, brand and managed markets marketing, and patient support.

David holds a BA in political science the University of Pittsburgh and an MBA in finance and supply chain from Rutgers Business School.

Authored Content


Tune into the second segment of the Avalere Health Essential Voice series focused on disease education. In this segment, experts from our Market Access practice discuss rare disease patient support programs and the need for stakeholder partnerships to address many of the barriers patients and their caregivers face.

Tune into the second segment of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, experts from our Market Access practice discuss rare disease patient support programs and the need for stakeholder partnerships to address many of the barriers patients and their caregivers face.